InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,425.20
(
0.54%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.31
(
-0.34%
)
Bitcoin
63,835.52
(
-0.67%
)
Post# of 253213
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: jq1234 post# 212648

Wednesday, 07/26/2017 4:13:04 PM

Wednesday, July 26, 2017 4:13:04 PM

Post# of 253213
>>5 out of 997 on 4mg arm during placebo controlled period

That is more concerning. I was just going by their PR which didn't break the events down into subgroups by dose.

Wonder if this is an off-target effect? That was never established one way or another with ponatinib's vascular events.

Peter
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up